glyceraldehyde 3-phosphate dehydrogenase (304-313) has been researched along with phosphatidylcholines in 1 studies
| Studies (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Trials (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Recent Studies (post-2010) (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) |
|---|---|---|---|---|---|
| 99 | 1 | 18 | 32,204 | 443 | 5,593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, PJ; Mudd, JB; Santrock, J | 1 |
1 other study(ies) available for glyceraldehyde 3-phosphate dehydrogenase (304-313) and phosphatidylcholines
| Article | Year |
|---|---|
Ozone does not react with human erythrocyte membrane lipids.
Topics: Acetylcholinesterase; Cholesterol; Cholinesterase Inhibitors; Erythrocyte Membrane; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Membrane Lipids; Membrane Proteins; Oxidation-Reduction; Ozone; Peptide Fragments; Phosphatidylcholines; Phosphatidylethanolamines | 1997 |